Literature DB >> 33392827

Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan.

Heng Zhai1, Yinzhang Lv2, Yu Xu1, Yi Wu1, Weiqi Zeng1, Tao Wang3, Xuebing Cao4, Yan Xu5.   

Abstract

Information about Parkinson's disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death.

Entities:  

Keywords:  COVID-19; Clinical characteristics; Clinical outcomes; Parkinson’s disease; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33392827      PMCID: PMC7779096          DOI: 10.1007/s00702-020-02283-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Teachers and research in special education.

Authors:  C Kiernan
Journal:  Spec Educ Forward Trends       Date:  1982-09

Review 2.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

3.  Multiple organ infection and the pathogenesis of SARS.

Authors:  Jiang Gu; Encong Gong; Bo Zhang; Jie Zheng; Zifen Gao; Yanfeng Zhong; Wanzhong Zou; Jun Zhan; Shenglan Wang; Zhigang Xie; Hui Zhuang; Bingquan Wu; Haohao Zhong; Hongquan Shao; Weigang Fang; Dongshia Gao; Fei Pei; Xingwang Li; Zhongpin He; Danzhen Xu; Xeying Shi; Virginia M Anderson; Anthony S-Y Leong
Journal:  J Exp Med       Date:  2005-07-25       Impact factor: 14.307

4.  Parkinsonism-hyperpyrexia syndrome: A case report and review of literature.

Authors:  Sandeep Grover; Ashirbad Sathpathy; Sai Chaitanya Reddy; Sahil Mehta; Navneet Sharma
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759

5.  ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.

Authors:  Mirjam Christ-Crain; Ewout J Hoorn; Mark Sherlock; Chris J Thompson; John A H Wass
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

6.  Clinical differences between pulmonary and extrapulmonary acute respiratory distress syndrome: a retrospective cohort study of prospectively collected data in Japan.

Authors:  Keisuke Anan; Kodai Kawamura; Moritaka Suga; Kazuya Ichikado
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

7.  Rapid worsening in Parkinson's disease may hide COVID-19 infection.

Authors:  Elodie Hainque; David Grabli
Journal:  Parkinsonism Relat Disord       Date:  2020-05-08       Impact factor: 4.891

8.  Outcome of Parkinson's Disease Patients Affected by COVID-19.

Authors:  Angelo Antonini; Valentina Leta; James Teo; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2020-05-28       Impact factor: 9.698

9.  Weight Loss in Parkinson's Disease: The Relationship with Motor Symptoms and Disease Progression.

Authors:  Maria G Cersosimo; Gabriela B Raina; Luis A Pellene; Federico E Micheli; Cristian R Calandra; Ricardo Maiola
Journal:  Biomed Res Int       Date:  2018-07-09       Impact factor: 3.411

10.  COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.

Authors:  Alfonso Fasano; Emanuele Cereda; Michela Barichella; Erica Cassani; Valentina Ferri; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  Mov Disord       Date:  2020-06-26       Impact factor: 9.698

View more
  9 in total

1.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

Review 2.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

3.  Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

Authors:  Conor Fearon; Alfonso Fasano
Journal:  Int Rev Neurobiol       Date:  2022-04-20       Impact factor: 4.280

4.  Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report.

Authors:  Walaa A Kamel; Ismail Ibrahim Ismail; Mohamed Ibrahim; Jasem Y Al-Hashel
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-05-17

5.  A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.

Authors:  Qiang Tang; Yanwei Liu; Yingfeng Fu; Ziyang Di; Kailiang Xu; Bo Tang; Hui Wu; Maojun Di
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

6.  A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method.

Authors:  Qian Zhang; Jian Li; Ling Weng
Journal:  Front Public Health       Date:  2022-07-26

Review 7.  The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.

Authors:  Jeswinder Sian-Hulsmann; Peter Riederer
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

Review 8.  The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.

Authors:  Amr Ehab El-Qushayri; Sherief Ghozy; Abdullah Reda; Ahmed Mostafa Ahmed Kamel; Alzhraa Salah Abbas; Adam A Dmytriw
Journal:  Rev Med Virol       Date:  2021-07-14       Impact factor: 11.043

Review 9.  Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?

Authors:  Lea Krey; Meret Koroni Huber; Günter U Höglinger; Florian Wegner
Journal:  Brain Sci       Date:  2021-12-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.